SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-17-219882
Filing Date
2017-06-30
Accepted
2017-06-30 16:04:30
Documents
16

Document Format Files

Seq Description Document Type Size
1 424B3 d384597d424b3.htm 424B3 4922851
2 GRAPHIC g384597g00j50.jpg GRAPHIC 78149
3 GRAPHIC g384597g02n59.jpg GRAPHIC 139274
4 GRAPHIC g384597g06i46.jpg GRAPHIC 73887
5 GRAPHIC g384597g15b63.jpg GRAPHIC 60553
6 GRAPHIC g384597g17n24.jpg GRAPHIC 41340
7 GRAPHIC g384597g17n61.jpg GRAPHIC 65596
8 GRAPHIC g384597g22m20.jpg GRAPHIC 83190
9 GRAPHIC g384597g32b79.jpg GRAPHIC 61077
10 GRAPHIC g384597g38c63.jpg GRAPHIC 35842
11 GRAPHIC g384597g42m09.jpg GRAPHIC 49387
12 GRAPHIC g384597g43z94.jpg GRAPHIC 90054
13 GRAPHIC g384597g60u35.jpg GRAPHIC 37697
14 GRAPHIC g384597g67q76.jpg GRAPHIC 46683
15 GRAPHIC g384597g72p97.jpg GRAPHIC 57386
16 GRAPHIC g384597g74s14.jpg GRAPHIC 165134
  Complete submission text file 0001193125-17-219882.txt   6419514
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-217993 | Film No.: 17942097
SIC: 2834 Pharmaceutical Preparations